Adamas Pharmaceuticals CEO Gregory Went's 2019 pay slips 19% to $2.7M
Adamas Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 23, 2020
Adamas Pharmaceuticals reported fiscal year 2019 executive compensation information on April 23, 2020.
In 2019, four executives at Adamas Pharmaceuticals received on average a compensation package of $1.8M, a 22% decrease compared to previous year.
Average pay of disclosed executives at Adamas Pharmaceuticals
Gregory T. Went, Chief Executive Officer, received $2.7M in total, which decreased by 19% compared to 2018.
Neil F. McFarlane, Chief Executive Officer, received a compensation package of $2.1M. 46% of the compensation package, or $957K, was in option awards.
Vijay Shreedhar, Chief Commercial Officer, earned $1.2M in 2019.
Christopher B. Prentiss, Chief Financial Officer, received $1.1M in 2019.
Related executives
You may also like
Source: SEC filing on April 23, 2020.